Cargando…

Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin – a retrospective analysis of medical charts and re-imbursement data of real-life patient populations

Objectives: To supplement the data collected in randomized clinical trials, the present study in patients with methicillin resistant Staphylococcus aureus (MRSA) pneumonia was conducted to explore the clinical effectiveness of linezolid and vancomycin in a routine clinical setting. Further, the over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilke, Michael H., Becker, Karsten, Kloss, Sebastian, Heimann, Sebastian M., Goldmann, Anton, Weber, Bertram, Pletz, Mathias W., Simon, Philipp, Petrik, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301724/ https://www.ncbi.nlm.nih.gov/pubmed/30671324 http://dx.doi.org/10.3205/id000028

Ejemplares similares

Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
por: Pletz, Mathias W, et al.
Publicado: (2010)

Linezolid vs Vancomycin in Induced Thrombocytopenia
por: Al-Harbi, Dimah, et al.
Publicado: (2022)

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
por: Fernández-Barat, Laia, et al.
Publicado: (2019)

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
por: Patel, Dipen A, et al.
Publicado: (2014)

Antimicrobial Synergistic Effects of Linezolid and Vancomycin with a Small Synthesized 2-Mercaptobenzothiazole Derivative: A Challenge for MRSA Solving
por: Muraglia, Marilena, et al.
Publicado: (2023)

Retrospective Study of Linezolid vs. Daptomycin for the Treatment of Vancomycin--resistant Enterococcal Bloodstream Infection
por: Rai, Rena, et al.
Publicado: (2017)

Animal experimental investigation on the efficacy of antibiotic therapy with linezolid, vancomycin, cotrimoxazole, and rifampin in treatment of periprosthetic knee joint infections by MRSA
por: Goetz, Julia, et al.
Publicado: (2022)

Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
por: Husain, Afzal, et al.
Publicado: (2018)

Vancomycin resistance among MRSA
por: Kumar, V. Anil
Publicado: (2012)

The Inhibition Effect of Linezolid With Reyanning Mixture on MRSA and its Biofilm is More Significant than That of Linezolid Alone
por: Zhang, Lulu, et al.
Publicado: (2022)

Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
por: Aktas, Gulseren
Publicado: (2020)

Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
por: Gorchynski, Julie, et al.
Publicado: (2008)

Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia
por: Abdelhady, Wessam, et al.
Publicado: (2019)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
por: Babalola, Olufemi Emmanuel
Publicado: (2020)

Epidemiology of clinically isolated methicillin-resistant Staphylococcus aureus (MRSA) and its susceptibility to linezolid and vancomycin in Egypt: a systematic review with meta-analysis
por: Azzam, Ahmed, et al.
Publicado: (2023)

Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience
por: McKinnell, James A., et al.
Publicado: (2015)

Host Gene Expression Profiling and In Vivo Cytokine Studies to Characterize the Role of Linezolid and Vancomycin in Methicillin-Resistant Staphylococcus aureus (MRSA) Murine Sepsis Model
por: Sharma-Kuinkel, Batu K., et al.
Publicado: (2013)

Comparison of Outcomes in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin vs. Non-Vancomycin Anti-MRSA Therapy
por: Stoneking, Carolyn, et al.
Publicado: (2017)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

Linezolid to treat urinary tract infections caused by vancomycin-resistant Enterococcus
por: Pontefract, Benjamin Alan, et al.
Publicado: (2020)

Optimization of Linezolid Dosing Regimens for Treatment of Vancomycin-Resistant Enterococci Infection
por: Santimaleeworagun, Wichai, et al.
Publicado: (2021)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
por: Wingler, Mary Joyce, et al.
Publicado: (2021)

Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus
por: Nakamura, Yoshihiko, et al.
Publicado: (2015)

Linezolid Has Unique Immunomodulatory Effects in Post-Influenza Community Acquired MRSA Pneumonia
por: Bhan, Urvashi, et al.
Publicado: (2015)

Genomics Insight into cfr-Mediated Linezolid-Resistant LA-MRSA in Italian Pig Holdings
por: Iurescia, Manuela, et al.
Publicado: (2023)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
por: Tian, Ye, et al.
Publicado: (2018)

1470. Linezolid for Treatment of Urinary Tract Infections Caused by Vancomycin-resistant Enterococci
por: Pontefract, Benjamin, et al.
Publicado: (2019)

Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection
por: Dorazio, Joshua, et al.
Publicado: (2023)

Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study
por: Alghanem, Sarah S., et al.
Publicado: (2023)

799 Linezolid vs Vancomycin in the Treatment of Nosocomial Pneumonia: A Cost-effectiveness Analysis Incorporating Results from the ZEPHyR Trial
por: Collins, Curtis, et al.
Publicado: (2014)

Applicability of vancomycin, meropenem, and linezolid in capillary microsamples vs. dried blood spots: A pilot study for microsampling in critically ill children
por: Xiaoyong, Xu, et al.
Publicado: (2023)

Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis
por: Bode, Christian, et al.
Publicado: (2015)

An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy
por: Watkins, Richard R, et al.
Publicado: (2012)

In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
por: El-Azizi, Mohamed, et al.
Publicado: (2005)

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization
por: Short, Elizabeth, et al.
Publicado: (2014)

No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period
por: Yayan, Josef, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ibcl34tsscrtcat51iontc9sb0